Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy-Reference-Cited by-同舟云学术

Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy

Published:2020 Issue:10 Volume:98 Page:743-747
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Di Lorenzo Giuseppe,Buonerba Luciana,Ingenito Concetta,Crocetto Felice,Buonerba Carlo,Libroia Annamaria,Sciarra Antonella,Ragone Gianluca,Sanseverino Roberto,Iaccarino Simona,Napodano Giorgio,Imbimbo Ciro,Leo Emilio,Kozlakidis Zisis,De Placido Sabino

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference12 articles.

1. Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, et al. Clinical Characteristics and Risk Factors Associated With COVID-19 Disease Severity in Patients With Cancer in Wuhan, China: A Multicentre, Retrospective, Cohort Study. Lancet Oncol; 2020 May 29;S1470-2045(20)30309-0. doi: https://doi.org/10.1016/S1470-2045(20)30309-0.

2. Di Lorenzo G, Di Trolio R. Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial Measures. Front Med (Lausanne). 2020 Apr;7:140.

3. Ingenito C, Buonerba L, Ferrara C, Busto G, Libroia A, Ragone G, et al. Coronavirus disease 2019 emergency and cancer in the south of Italy. What’s new for the oncologist? Front Med (Lausanne). 2020 May;7:189.

4. Gillessen S, Powles T. Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic. Eur Urol. 2020 Jun;77(6):667–8.

5. Gubbels Bupp MR, Jorgensen TN. Androgen-Induced Immunosuppression. Front Immunol. 2018 Apr;9:794.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis reveals that CBX2 promotes enzalutamide resistance in prostate cancer;European Journal of Medical Research;2024-08-22

2. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers;Critical Reviews in Oncology/Hematology;2024-04

3. Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis;Critical Reviews in Oncology/Hematology;2024-04

4. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

5. Evaluation of the Reliability and the Performance of Magnetic Resonance Imaging Radiomics in the Presence of Randomly Generated Irrelevant Features for Prostate Cancer;Diagnostics;2023-12-01